LULIZUMAB PEGOL
UNII LCT264LTYE

Substance Identification & Data

This profile provides standardized clinical and technical data for Lulizumab Pegol, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LCT264LTYE.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1421830-13-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

LCT264LTYE

CAS Registry Number

1421830-13-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LULIZUMAB PEGOL

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C175727

National Cancer Institute reference terminology for clinical and research data.

INN ID

9940

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

AB-119

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lulizumab Pegol. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.